Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer

LESSONS LEARNED. The androgen receptor (AR) is present in most breast cancers (BC), but its exploitation as a therapeutic target has been limited. This study explored the activity of dehydroepiandrosterone (DHEA), a precursor being transformed into androgens within BC cells, in combination with an a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pietri, Elisabetta, Massa, Ilaria, Bravaccini, Sara, Ravaioli, Sara, Tumedei, Maria Maddalena, Petracci, Elisabetta, Donati, Caterina, Schirone, Alessio, Piacentini, Federico, Gianni, Lorenzo, Nicolini, Mario, Campadelli, Enrico, Gennari, Alessandra, Saba, Alessandro, Campi, Beatrice, Valmorri, Linda, Andreis, Daniele, Fabbri, Francesco, Amadori, Dino, Rocca, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656524/
https://www.ncbi.nlm.nih.gov/pubmed/30591548
http://dx.doi.org/10.1634/theoncologist.2018-0243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656524/
https://www.ncbi.nlm.nih.gov/pubmed/30591548
http://dx.doi.org/10.1634/theoncologist.2018-0243

Ejemplares similares